Halley E. Gilbert - 01 Jun 2022 Form 4 Insider Report for Arcutis Biotherapeutics, Inc. (ARQT)

Role: Director
Signature: /s/ Scott Burrows, as Attorney-in-Fact for Halley E. Gilbert
Issuer symbol: ARQT
Transactions as of: 01 Jun 2022
Net transactions value: $0
Form type: 4
Filing time: 03 Jun 2022, 16:56:16 UTC
Previous filing: 03 Mar 2022
Next filing: 17 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ARQT	Common Stock	Award	$0	+4,312		$0.000000	4,312	01 Jun 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ARQT	Stock Option (Right to Buy)	Award	$0	+11,796		$0.000000	11,796	01 Jun 2022	Common Stock	11,796	$20.29	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 4,312 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.
F2	The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of June 1, 2022.